Exhibit 23.2


Consent of Independent Registered Public Accounting Firm


Checkpoint Therapeutics, Inc.

Waltham, MA


We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 28, 2022, relating to the financial statements of Checkpoint Therapeutics, Inc., appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.


We also consent to the reference to us under the caption “Experts” in the Prospectus.


/s/ BDO USA, P.C.


New York, New York


November 17, 2023